1st Jul 2015 13:56
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares ('ADSs') of GlaxoSmithKline plc ('Company').
On 30 June 2015, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £13.45 per Ordinary Share, and notional ADSs at a price of $42.20 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2015 to 30 June 2015:
Non Executive Director | Ordinary Shares | No. of ADSs |
Sir Philip Hampton | 2,730.912 | |
Professor Sir Roy Anderson | 673.792 | |
Dr Stephanie Burns | 539.199 | |
Stacey Cartwright | 534.387 | |
Lynn Elsenhans | 1,070.720 | |
Judy Lewent | 457.147 | |
Sir Deryck Maughan | 1,359.719 | |
Dr Daniel Podolsky | 1,019.789 | |
Urs Rohner | 589.536 | |
Hans Wijers | 534.387 | |
The Company and the Non-Executive Directors were informed of these allocations on 1 July 2015.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
1 July 2015
Related Shares:
Glaxosmithkline